The post Trying To Secure Playoff Spots, Mets And Yankees Struggle With Pesky Miami Marlins appeared on BitcoinEthereumNews.com. From left to right, Miami Marlins outfielders Victor Mesa Jr., Joey Wiemer and Jakob Marsee celebrate after defeating the New York Mets 5-1, Sunday Aug. 31, 2025 in New York. (AP Photo/Noah K. Murray) It happens every year and becomes more prevalent since the playoffs turned into a four-round format in 2022 because there are more meaningful games in the final weeks. It also means one or two potential teams with losing records may succeed at messing up some type of playoff aspiration for a contender. From the New York baseball perspective, the team messing things up might be the Marlins, a least based on the combined 56 games the Mets and Yankees played. While the Yankees won 16 of those and the Mets won 11 times, three losses apiece were against the Marlins who are vastly improved from last year when it went 62-100 — a year after winning 84 times in the regular season to reach a wild-card series with the Phillies. Recent evidence points to the Marlins being the kind of bugaboo for the New York teams, who face differing degrees of difficulty in their quests to become division winners. The Yankees head into September three games out with 12 straight against the Astros, Blue Jays, Tigers and Red Sox before a season-ending 13-game stretch against teams with losing records. The Mets enter September seven games out with a group who set team records for offense in a month but struggle to pitch on a frequent basis. Of their 26 games, 20 are against teams with winning records while three are against the pesky Marlins and three are against the careening Nationals. Although they slipped back under .500 after briefly getting there, the Marlins went a combined 6-1 against the Yankees and Mets in August. The Yankees… The post Trying To Secure Playoff Spots, Mets And Yankees Struggle With Pesky Miami Marlins appeared on BitcoinEthereumNews.com. From left to right, Miami Marlins outfielders Victor Mesa Jr., Joey Wiemer and Jakob Marsee celebrate after defeating the New York Mets 5-1, Sunday Aug. 31, 2025 in New York. (AP Photo/Noah K. Murray) It happens every year and becomes more prevalent since the playoffs turned into a four-round format in 2022 because there are more meaningful games in the final weeks. It also means one or two potential teams with losing records may succeed at messing up some type of playoff aspiration for a contender. From the New York baseball perspective, the team messing things up might be the Marlins, a least based on the combined 56 games the Mets and Yankees played. While the Yankees won 16 of those and the Mets won 11 times, three losses apiece were against the Marlins who are vastly improved from last year when it went 62-100 — a year after winning 84 times in the regular season to reach a wild-card series with the Phillies. Recent evidence points to the Marlins being the kind of bugaboo for the New York teams, who face differing degrees of difficulty in their quests to become division winners. The Yankees head into September three games out with 12 straight against the Astros, Blue Jays, Tigers and Red Sox before a season-ending 13-game stretch against teams with losing records. The Mets enter September seven games out with a group who set team records for offense in a month but struggle to pitch on a frequent basis. Of their 26 games, 20 are against teams with winning records while three are against the pesky Marlins and three are against the careening Nationals. Although they slipped back under .500 after briefly getting there, the Marlins went a combined 6-1 against the Yankees and Mets in August. The Yankees…

Trying To Secure Playoff Spots, Mets And Yankees Struggle With Pesky Miami Marlins

From left to right, Miami Marlins outfielders Victor Mesa Jr., Joey Wiemer and Jakob Marsee celebrate after defeating the New York Mets 5-1, Sunday Aug. 31, 2025 in New York.

(AP Photo/Noah K. Murray)

It happens every year and becomes more prevalent since the playoffs turned into a four-round format in 2022 because there are more meaningful games in the final weeks.

It also means one or two potential teams with losing records may succeed at messing up some type of playoff aspiration for a contender.

From the New York baseball perspective, the team messing things up might be the Marlins, a least based on the combined 56 games the Mets and Yankees played.

While the Yankees won 16 of those and the Mets won 11 times, three losses apiece were against the Marlins who are vastly improved from last year when it went 62-100 — a year after winning 84 times in the regular season to reach a wild-card series with the Phillies.

Recent evidence points to the Marlins being the kind of bugaboo for the New York teams, who face differing degrees of difficulty in their quests to become division winners.

The Yankees head into September three games out with 12 straight against the Astros, Blue Jays, Tigers and Red Sox before a season-ending 13-game stretch against teams with losing records.

The Mets enter September seven games out with a group who set team records for offense in a month but struggle to pitch on a frequent basis. Of their 26 games, 20 are against teams with winning records while three are against the pesky Marlins and three are against the careening Nationals.

Although they slipped back under .500 after briefly getting there, the Marlins went a combined 6-1 against the Yankees and Mets in August. The Yankees entered Miami on Aug. 1 riding the positive buzz from adding relievers David Bednar, Camilo Doval and Jake Bird along with utilityman Jose Caballero at the July 31 trade deadline and got outscored 22-15 in a three-game sweep by the Marlins.

The nightmarish series of events in Miami sent the Yankees from 3 1/2 to 4 1/2 games behind the Toronto Blue Jays in the AL East. The Yankees eventually dropped 6 1/2 games out on seven occasions and did not really start making a dent in their deficit until this week when they won seven straight to get within two games out before taking a 3-2 loss to the White Sox on Sunday.

The Mets won four of six games from the Marlins in the opening weeks when they went 21-10 through the end of April on the way to a 45-24 record and a 5 1/2 game lead over the Phillies in the NL East. Now the Mets are 29-40 in their past 69 games, and the Marlins outplayed them three times.

The Marlins capitalized on three errors in a 7-4 win on Thursday. After taking a 19-8 loss Friday while the Mets unveiled Jonah Tong for five inning, the Marlins scored five in the first inning, withstood two homers by Juan Soto in an 11-8 win Saturday and easily earned a 5-1 victory Sunday.

The scrappiness and spoiler mentality were evident Sunday, starting with Sandy Alcantara making the Mets appear lifeless for most of his seven innings. Alcantara was among the more prominent starters rumored to go at the deadline and it seemed reasonable to think the Mets were a team who could check in on him and even make the effort to obtain him.

The Marlins will not finish with 100 losses and likely will avoid 95 if not 90. They get another crack at messing up for the Mets with a season-ending series at home. There could be similar apprehension to 2007 and 2008 if the Mets do not do enough between Sunday and the last weekend to secure a playoff berth.

“There are a lot of young players that are hungry all the time. They want to be out there, have an opportunity to play the game and win the game,” Alcantara said.

The Marlins may also potentially mess things for the Phillies quest at avoiding the NL’s third-best record or Detroit’s bid at staying as the team with the top record in the AL.

For now, they are potential spoilers to the Yankees and Mets division title hopes. The Mets entered this weekend coming off a three-game sweep of the Phillies, an experienced team hardly fazed by their division lead by reduced to four games.

And then they killed the buzz in matter resembling how the Yankees did the same when each trade acquisition contributed to a walk-off 13-12 loss, the offense mustered two hits off Eury Perez in the second game and Luis Gil struggled in his debut in the series finale.

This time, other than the record-setting events coupled with Tong’s hyped debut, the Mets were a sloppy downer and failed to handle a pesky opponent properly.

“It means a lot,” Marlins leadoff hitter Xavier Edwards said. “You always want to get on the road and start a road trip while hot, which we did. I feel like we usually play the Mets pretty tough. Just kind of one of those teams that we kind of matchup well against and play them tough whether it’s here or Miami.”

There is certainly precedent for this thing occurring in recent New York baseball history.

In 2022 the Mets finished with 101 wins, their second-most in team history. Three they did not obtain were at home against the 74-88 Chicago Cubs from Sept. 12-14 when they were outscored 15-6 and saw a division lead trimmed to a half-game.

It was not the sole reason for the Mets blowing a seven-game lead by going 28-22 the rest of the 2022 season but it certainly did not help, especially when they lost the division lead on the final weekend of the season in Atlanta where they also lost the tiebreaker.

On all accounts, the 2018 regular season was successful for the Yankees in manager Aaron Boone’s first season after a decade of Joe Girardi. They won 100 games but only 12 of 19 against the 47-115 Baltimore Orioles while the Red Sox won 16 of 19 meetings with the Orioles to help claim the division by eight games and eventually a fourth championship since 2004

By any measure the Yankees and Mets are fairly secure in their wild-card situations. If the situation becomes a little skittish in the final weeks with those spots in jeopardy, the underwhelming results against the Marlins might be cited amongst other issues.

Source: https://www.forbes.com/sites/larryfleisher/2025/09/01/trying-to-secure-playoff-spots-mets-and-yankees-struggle-with-pesky-miami-marlins/

Market Opportunity
Sidekick Logo
Sidekick Price(K)
$0.005664
$0.005664$0.005664
+35.79%
USD
Sidekick (K) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale

5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale

BullZilla, World Liberty Financial, MoonBull, La Culex, and Polkadot (DOT) are taking the spotlight among emerging and established crypto projects […] The post 5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale appeared first on Coindoo.
Share
Coindoo2025/10/18 08:15
Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26